At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 28 enrolled
Drug / intervention
Apremilast +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1, Open-label, Two Part Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Subjects
In Brief
A Phase 1 clinical trial evaluating Apremilast and Placebo for Pharmacokinetics. Completed, enrolled 28 participants across 1 site.
Detailed Summary
This two-part study was designed to evaluate the pharmacokinetics (PK) of single and multiple doses of apremilast in healthy adult Korean males.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPharmacokinetics
CountriesSouth Korea
Collaborators--
Timeline
Phase 1CompletedFinished
2017201820192020202120222023202420252026
First PostedJun 2016
Enrollment StartJun 2016
Primary CompletionAug 2016
TodayJul 2026
First PostedJun 16, 2016
Enrollment StartJun 22, 2016
Primary CompletionAug 5, 2016
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.0 years ago
Interventions
Apremilastdrug
Tablet for oral administration
Placebodrug
Tablet for oral administration